Logo

Thrive Earlier Detection: Matt Franklin, Sarah Larson, Semi Trotto

Mar 17, 2020

Thrive Earlier Detection has announced the appointment of Matt Franklin as its chief commercial officer, the appointment of Sarah Larson to its board of directors, and Semi Trotto's promotion to chief people officer.

Franklin holds more than 20 years of business, commercial, and strategic marketing experience in the diagnostics, life sciences, and technology industries. Most recently, he served as chief business officer at ArcherDx, where he was responsible for various business development activities. Prior to Archer, he held senior leadership roles at both Foundation Medicine and Boston Scientific.

Larson currently serves as partner and chief human resources officer at Third Rock Ventures where she is responsible for human resources and also provides guidance and counsel to the firm's portfolio companies, focusing on areas of human capital, leadership development, and culture creation. She has more than 20 years of experience in human resources and leadership development.

Trotto, a member of Thrive's founding management team, most recently served as senior vice president and head of human resources. Before joining Thrive, she held leadership positions in human resources at Editas Medicine, Baxalta, and Bristol-Myers Squibb. She has more than 20 years of experience in the field overall.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.